Literature DB >> 22020140

Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Ream Al-Hasani1, Michael R Bruchas.   

Abstract

Opioid receptors have been targeted for the treatment of pain and related disorders for thousands of years and remain the most widely used analgesics in the clinic. Mu (μ), kappa (κ), and delta (δ) opioid receptors represent the originally classified receptor subtypes, with opioid receptor like-1 (ORL1) being the least characterized. All four receptors are G-protein coupled and activate inhibitory G proteins. These receptors form homo- and heterodimeric complexes and signal to kinase cascades and scaffold a variety of proteins.The authors discuss classic mechanisms and developments in understanding opioid tolerance and opioid receptor signaling and highlight advances in opioid molecular pharmacology, behavioral pharmacology, and human genetics. The authors put into context how opioid receptor signaling leads to the modulation of behavior with the potential for therapeutic intervention. Finally, the authors conclude there is a continued need for more translational work on opioid receptors in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22020140      PMCID: PMC3698859          DOI: 10.1097/ALN.0b013e318238bba6

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  190 in total

1.  Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects.

Authors:  J Gelernter; H Kranzler; J Cubells
Journal:  Mol Psychiatry       Date:  1999-09       Impact factor: 15.992

2.  Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Eur J Pharmacol       Date:  2011-04-19       Impact factor: 4.432

3.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

Review 4.  Heterodimerization of g protein-coupled receptors: specificity and functional significance.

Authors:  Steven C Prinster; Chris Hague; Randy A Hall
Journal:  Pharmacol Rev       Date:  2005-09       Impact factor: 25.468

5.  Delta-opioid receptors activate ERK/MAP kinase via integrin-stimulated receptor tyrosine kinases.

Authors:  Daniela A Eisinger; Hermann Ammer
Journal:  Cell Signal       Date:  2008-09-05       Impact factor: 4.315

6.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

7.  Effects of C-terminal modifications of GEC1 protein and gamma-aminobutyric acid type A (GABA(A)) receptor-associated protein (GABARAP), two microtubule-associated proteins, on kappa opioid receptor expression.

Authors:  Chongguang Chen; Yulin Wang; Peng Huang; Lee-Yuan Liu-Chen
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

8.  Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.

Authors:  Yulin Wang; Kang Tang; Saadet Inan; Daniel Siebert; Ulrike Holzgrabe; David Y W Lee; Peng Huang; Jian-Guo Li; Alan Cowan; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2004-09-21       Impact factor: 4.030

9.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Extracellular signal-regulated kinase/mitogen-activated protein kinases block internalization of delta-opioid receptors.

Authors:  Daniela A Eisinger; Rüdiger Schulz
Journal:  J Pharmacol Exp Ther       Date:  2004-01-23       Impact factor: 4.030

View more
  262 in total

Review 1.  Ligand-directed signalling within the opioid receptor family.

Authors:  Amynah A Pradhan; Monique L Smith; Brigitte L Kieffer; Christopher J Evans
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa.

Authors:  Itziar Urizar-Arenaza; Nerea Osinalde; Vyacheslav Akimov; Michele Puglia; Luz Candenas; Francisco Maria Pinto; Iraia Muñoa-Hoyos; Marta Gianzo; Roberto Matorras; Jon Irazusta; Blagoy Blagoev; Nerea Subiran; Irina Kratchmarova
Journal:  Mol Cell Proteomics       Date:  2019-01-08       Impact factor: 5.911

3.  Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.

Authors:  Amirhossein Mafi; Soo-Kyung Kim; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

4.  Opioid signaling in mast cells regulates injury responses associated with heterotopic ossification.

Authors:  Lixin Kan; Amelia A Mutso; Tammy L McGuire; Apkar Vania Apkarian; John A Kessler
Journal:  Inflamm Res       Date:  2013-12-11       Impact factor: 4.575

Review 5.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

6.  Synthesis and biological activity of the novel indanedione anticoagulant rodenticides containing fluorine.

Authors:  Feng Chen; Liping Liu; Zengguo Bai; Tianhua Zhang; Keke Zhao
Journal:  Bioengineered       Date:  2016-10-19       Impact factor: 3.269

Review 7.  An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure.

Authors:  Steven D Stockton; Lakshmi A Devi
Journal:  Neuropsychopharmacology       Date:  2013-09-18       Impact factor: 7.853

8.  The Development of a Macromolecular Analgesic for Arthritic Pain.

Authors:  Laura Weber; Xiaobei Wang; Rongguo Ren; Xin Wei; Gang Zhao; Junxiao Yang; Hongjiang Yuan; Huiling Pang; Hanjun Wang; Dong Wang
Journal:  Mol Pharm       Date:  2019-02-14       Impact factor: 4.939

Review 9.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

Review 10.  Opioids and Cancer Mortality.

Authors:  Jaya Amaram-Davila; Mellar Davis; Akhila Reddy
Journal:  Curr Treat Options Oncol       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.